Literature DB >> 27861676

[Obtaining drugs for hypertension and diabetes through the Brazilian People's Pharmacy Program: results of the National Health Survey, 2013].

Karen Sarmento Costa1, Noemia Urruth Leão Tavares2, Sotero Serrate Mengue3, Marco Aurélio Pereira1, Deborah Carvalho Malta4, Jarbas Barbosa da Silva5.   

Abstract

OBJECTIVE: to describe the proportion of hypertensive and diabetic patients who reported getting medicines to control these diseases via the Brazilian People's Pharmacy Program, according to sociodemographic factors.
METHODS: this was a population-based descriptive study using 2013 National Health Survey data on individuals aged over 18 years.
RESULTS: around one third of hypertensive individuals (35.9%; 95%CI 34.1-37.7) and more than half of those with diabetes (57.4%; 95%CI 54.2-60.2%) had got at least one kind of medication via the Program, there being some differences between the country's regions. Among patients with diabetes, higher rates of getting medication were found in black people (69.4%; 95%CI 60.8-77.9) and those with less schooling (0-8 years) (63.9%; 95%CI 60.2-67.7), with no significant differences between age groups or sex.
CONCLUSION: obtaining at least one kind of medication to treat hypertension and diabetes via the Program was high, especially among the underprivileged.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27861676     DOI: 10.5123/S1679-49742016000100004

Source DB:  PubMed          Journal:  Epidemiol Serv Saude        ISSN: 1679-4974


  4 in total

Review 1.  Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey.

Authors:  Jose Rocha Faria-Neto; Carlos Yarleque; Luiz Fernando Vieira; Eliane Naomi Sakane; Raul D Santos
Journal:  BMC Cardiovasc Disord       Date:  2022-05-21       Impact factor: 2.174

2.  Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS).

Authors:  Karen Sarmento Costa; Noêmia Urruth Leão Tavares; José Miguel do Nascimento; Sotero Serrate Mengue; Juliana Álvares; Augusto Afonso Guerra; Francisco de Assis Acurcio; Orlando Mario Soeiro
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

3.  Impacts of a Brazilian pharmaceutical program on the health of chronic patients.

Authors:  Aléssio Tony Cavalcanti de Almeida; Edvaldo Batista de Sá; Fabiola Sulpino Vieira; Rodrigo Pucci de Sá E Benevides
Journal:  Rev Saude Publica       Date:  2019-01-31       Impact factor: 2.106

4.  Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the "Farmácia popular" program in Brazil: an interrupted time series study.

Authors:  Isabel Cristina Martins Emmerick; Mônica Rodrigues Campos; Rondineli Mendes da Silva; Luisa Arueira Chaves; Andréa Dâmaso Bertoldi; Dennis Ross-Degnan; Vera Lucia Luiza
Journal:  BMC Public Health       Date:  2020-01-08       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.